Overview Indian manufacturers of medical devices have voiced strong concerns to the Central government regarding the approval grants for the import of refurbished and reconditioned medical devices. They argue that this move poses significant risks to India’s healthcare ecosystem, which has invested heavily in indigenous research, engineering, and manufacturing under the “ Make in India ” vision. The manufacturers believe that allowing such imports undermines regulatory integrity and creates an uneven playing field for domestic innovators. Key Developments Regulatory Contradiction: Despite the Central Drugs Standard Control Organisation’s (CDSCO) ban on the import of refurbished medical equipment, approvals are being granted, causing confusion and unfair advantage. Legal Challenge: The Patient Safety and Access Initiative of India Foundation has filed a writ petition before the Delhi High Court seeking a ban on refurbished imports, highlighting concerns that India risks becoming a dumping ground for used medical equipment. Uneven Competition: Identical import duties on new and used medical equipment allow refurbished global systems to compete directly with high-value Indian devices, suppressing domestic demand and discouraging local innovation. Patient Safety Risks: The absence of a comprehensive safety and regulatory framework for used equipment sales and third-party service providers creates patient safety risks and enables an unregulated market. Concerns Raised by Stakeholders Undermining Domestic Industry: Stakeholders argue that the practice weakens the domestic medical device industry and undermines the work of innovators who are creating cutting-edge, globally competitive devices. Dumping Ground: There is a fear that India will become a dumping ground for medical electronic waste under the guise of refurbished equipment, threatening to flood the market with outdated technology. Regulatory Integrity: Approvals for refurbished imports risk undermining regulatory integrity, especially with the matter currently sub judice before the courts. Government Tendering: Government tendering processes often disadvantage Indian high-end medical equipment manufacturers by demanding unnecessary advanced features and foreign certifications instead of relying on Indian standards. Impact on Healthcare Ecosystem The stakeholders emphasize that imported machines often carry outdated technology, unpredictable performance, and unreliable spare-part support, resulting in frequent breakdowns and compromised diagnostic accuracy. Many refurbished systems do not meet the latest global safety standards, and their shorter lifespan and hidden defects create avoidable risks during critical medical procedures. The focus should be on adopting modern, efficient, and locally manufactured equipment that ensures long-term reliability, better clinical outcomes, and supports the growth of India’s medical technology ecosystem. UPSC Relevance This issue is relevant to GS3 (Economy, Infrastructure, Science and Technology) and GS2 (Government Policies and Interventions) . It highlights the challenges in balancing economic interests with public health and safety, and the importance of regulatory frameworks in promoting domestic manufacturing and innovation. Potential UPSC Questions Analyze the potential impacts of allowing the import of refurbished medical devices on India's healthcare sector and domestic manufacturing capabilities. Discuss the regulatory challenges in ensuring patient safety while promoting affordable healthcare solutions in India. Evaluate the effectiveness of the 'Make in India' initiative in the medical device industry, considering the competition from imported refurbished equipment.